Management Record

Management Record

Elastic's management record is mixed but, on balance, reassuring on the test that matters for a per-share owner: turning growth into cash. The FY2025 sales-segmentation stumble was self-inflicted and drew a securities class action, yet management diagnosed it and delivered full-year revenue of $1.483 billion — above the guidance it had set before the cut. Capital allocation is the weaker mark: the first buyback front-loaded roughly $300 million at about $80 a share months before the stock fell to the high-$50s.

Promise versus delivery: the FY2025 stumble

In May 2024, management guided FY2025 revenue to $1.468–1.480 billion, about 16% growth [1]. One quarter later it cut the range to $1.436–1.44 billion, about 14% [2]. The cause was not the market. Management had reorganized its U.S. sales force at the start of the fiscal year — expanding the strategic segment, cutting accounts per rep, and carving out greenfield territories — and the disruption caused the volume of customer commitments closed in the quarter to fall short of plan [3]. Management attributed the shortfall to its own reorganization, calling it a "mixed quarter" driven by "sales segmentation changes we made" [4].

Loading...

Sources: initial FY2025 guide, Q4 FY2024 transcript [5]; revised guide, Q1 FY2025 transcript [6]; actuals, FY2026 Annual Report (Form 10-K) [7].

The delivery side is the part that matters for trust. FY2025 revenue landed at $1.483 billion — 17% growth, and higher than even the $1.468–1.480 billion the company had guided before the stumble [8]. The CEO had told investors in August 2024 that fixing sales execution was "my absolute No. 1 priority and my commitment" [9], and FY2026 growth held at 17% to $1.739 billion [10]. A commitment that was met, and a guide that proved conservative, is the outcome a skeptic wants to see after a self-inflicted miss. The durability of that recovery is examined in Growth Engine.

Two qualifications keep this from being a clean pass. First, the miss exposed a planning weakness: when an analyst asked why the original guide carried no cushion for a reorganization management chose to run, the CFO conceded the team had anticipated "some degree of change" but that "the magnitude of what we did, obviously, was much larger" [11]. Guidance was built without adequate margin for a risk the company created itself.

Second, the episode carries live legal tail-risk. In February 2025 a shareholder filed a putative securities class action — now captioned In re Elastic N.V. Securities Litigation — against the company, CEO Ashutosh Kulkarni, and former CFO Janesh Moorjani, alleging misleading statements over the May–August 2024 window; an amended complaint extended the class period back to June 2023 [12]. Elastic filed a motion to dismiss in October 2025; as of the FY2026 filing it was pending, and the company could "neither predict the ultimate outcome of the litigation nor estimate any range of possible losses" [13].

Capital allocation: the first buyback bought high

Elastic's first-ever return of capital is a cleaner test of judgment, and it went less well. The board authorized a $500 million repurchase program in October 2025 [14]. The company then moved fast: it bought 4.4 million shares for $340.0 million in FY2026 at a weighted-average price of $76.91 [15]. The bulk — roughly $300 million — was spent in the first three months at about $80 a share; by February 2026 the pace had slowed to $40 million at $61.28 [16]. At the late-June 2026 price near $57, that first tranche is roughly a quarter underwater.

Loading...

Source: derived from FY2026 Annual Report (Form 10-K) share-repurchase disclosures; the $340.0M total at $76.91 avg and the February window at $61.28 imply a ~$300M earlier tranche near $80 [17] [18].

Deployed FY2026 ($M)

$340

Avg Price Paid

$76.91

Price, 30 Jun 2026

$56.95

Authorization Left ($M)

$160

Sources: repurchase total, average price, and remaining authorization, FY2026 Annual Report (Form 10-K) [19]; price as reported, 30 June 2026.

Two readings coexist, and both are fair. The charitable one: with net cash of roughly $800 million (detailed in What the Price Pays) and no dividend, buying stock the board considered undervalued is a defensible use of surplus, and $160 million of dry powder remains for lower prices [20]. The critical one: front-loading three-quarters of a maiden program at the top of the stock's recent range, just before a drawdown, is exactly the buy-high pattern that erodes rather than builds per-share value. On a first outing, it is a demerit.

There is a subtler point that connects back to Owner Economics. Despite spending $340 million, Elastic's share count fell only from 105.5 million to 104.8 million — because employee stock issuance added about 3.6 million shares even as buybacks retired 4.4 million [10]. The first buyback, in other words, largely mopped up one year of dilution rather than shrinking the base. Until stock-based compensation falls further as a share of revenue, repurchases will function as dilution offset, not per-share compounding.

Pay, structure, and the people

Executive pay is equity-heavy and sized to the peer group rather than to the stumble. For FY2025 the CEO received $14.3 million, 91% of it in stock; the founder-CTO Shay Banon took $4.7 million; and the CEO pay ratio was 64:1 against a median employee of $225,619 [21]. Pay is almost entirely restricted stock rather than options or cash bonus, which aligns executives with the share price — the same price the buyback and the dilution turn on.

No Results

Source: FY2025 Summary Compensation Table, 2025 Definitive Proxy Statement (Form DEF 14A) [22].

The finance seat is the instability worth flagging. The CFO chair turned over twice during the stumble year: long-serving CFO-and-COO Janesh Moorjani — the executive named alongside the CEO in the class action — departed, Eric Prengel served as interim CFO, and Navam Welihinda took the role near fiscal year-end (his $85,417 FY2025 salary reflects only a few months) [23]. A finance leadership change concurrent with a guidance-setting failure is a combination that warrants watching the next few forecasting cycles closely.

Board structure is a genuine offset. The eight-person board has six independent directors, and the roles of chair and CEO are separated — the non-executive chair and lead independent director is Chetan Puttagunta of Benchmark, and both company co-founders sit on the board (Banon as CTO, Steven Schuurman as a non-executive director) [24]. The current CEO, Kulkarni, was promoted from Chief Product Officer in January 2022 when Banon stepped back to CTO — a founder-led company that has already navigated one orderly CEO handoff [25].

One structural feature cuts against minority holders. Elastic flags that its executives and directors "together beneficially own a significant amount" of the shares and can "exercise significant influence" over matters requiring shareholder approval [26]; market data put insider ownership near 13%, high for a company this size and largely tied to Banon's founder stake. That concentration aligns the largest insiders with the share price, but it also concentrates control. Insider selling, for context, has been dominated by automatic sell-to-cover on RSU vesting rather than discretionary exits — a distinction that matters before reading share sales as a signal.

The overall read: this is a management team that executes and recovers, governed by an independent, founder-anchored board, but whose two most consequential recent decisions — the sales reorganization and the timing of the first buyback — were both mistimed. Trust here rests on delivery, which has been good, more than on planning or capital-allocation instinct, which have not yet been. What would change the read in either direction is the next forecasting cycle under a new CFO and the price at which the balance of the buyback is spent.